Skip to main content

Advertisement

SpringerLink
Log in

Dendritic cells transfected with hepatocellular carcinoma (HCC) total RNA induce specific immune responses against HCC in vitro and in vivo

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Background

Immunotherapy is an effective method for preventing metastasis and recurrence of carcinoma. Hepatocellular carcinoma (HCC) is a common malignancy with a high rate of recurrence, and has not successfully been introduced to immunotherapy.

Methods

Peripheral blood mononuclear cells were isolated from whole blood of HCC patients and stimulated to transform into dendritic cells (DCs). These DCs were then transfected with RNA extracted from HepG-2 hepatoma cells to induce expression of specific antigens.

Results

The transfected DCs stimulated T lymphocytes to produce cytotoxic T lymphocytes, which specifically attacked HepG-2 cells. Injection of T lymphocytes from HCC patients and transfected DCs into severe combined immunodeficiency mice limited the growth of HepG-2 tumors.

Conclusion

A specific immune response against hepatoma can be generated in vivo by administering DCs transfected with RNA from a specific tumor. This method may have therapeutic application in humans to reduce recurrence of HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767–811.

    Article  CAS  PubMed  Google Scholar 

  2. Heufler C, Koch F, Stanzl U, Topar G, Wysocka M, Trinchieri G, et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol. 1996;26:659–68.

    Article  CAS  PubMed  Google Scholar 

  3. Nouri-Shirazi M, Banchereau J, Fay J, Palucka K. Dendritic cell based tumor vaccines. Immunol Lett. 2000;74:5–10.

    Article  CAS  PubMed  Google Scholar 

  4. Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED, et al. Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res. 2000;6:1755–66.

    CAS  PubMed  Google Scholar 

  5. Halliday GM, Le S. Transforming growth factor-beta produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin. Int Immunol. 2001;13:1147–54.

    Article  CAS  PubMed  Google Scholar 

  6. Ohm JE, Carbone DP. VEGF as a mediator of tumor-associated immunodeficiency. Immunol Res. 2001;23:263–72.

    Article  CAS  PubMed  Google Scholar 

  7. Cao H, Verge V, Baron C, Martinache C, Leon A, Scholl S, et al. In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy. J Hematother Stem Cell Res. 2000;9:183–94.

    Article  CAS  PubMed  Google Scholar 

  8. Garderet L, Cao H, Salamero J, Vergé V, Tisserand E, Scholl S, et al. In vitro production of dendritic cells from human blood monocytes for therapeutic use. J Hematother Stem Cell Res. 2001;10:553–67.

    Article  CAS  PubMed  Google Scholar 

  9. Zheng Z, Takahashi M, Narita M, Toba K, Liu A, Furukawa T, et al. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha. J Hematother Stem Cell Res. 2000;9:453–64.

    Article  CAS  PubMed  Google Scholar 

  10. Ramadan G, Schmidt RE, Schubert J. In vitro generation of human CD86+ dendritic cells from CD34 + haematopoietic progenitors by PMA and in serum-free medium. Clin Exp Immunol. 2001;125:237–44.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Hagihara M, Li C, Gansuvd B, Munkhbat B, Inoue H, Shimakura Y, et al. Extensive and long-term ex vivo production of dendritic cells from CD34 positive umbilical cord blood or bone marrow cells by novel culture system using mouse stroma. J Immunol Methods. 2001;253:45–55.

    Article  CAS  PubMed  Google Scholar 

  12. Mitchell DA, Nair SK. RNA-transfected dendritic cells in cancer immunotherapy. J Clin Invest. 2000;106:1065–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Saenz-Badillos J, Amin SP, Granstein RD. RNA as a tumor vaccine: a review of the literature. Exp Dermatol. 2001;10:143–54.

    Article  CAS  PubMed  Google Scholar 

  14. Kariko K, Kuo A, Barnathan ES, Langer DJ. Phosphate-enhanced transfection of cationic lipid-complexed mRNA and plasmid DNA. Biochim Biophys Acta. 1998;1369:320–34.

    Article  CAS  PubMed  Google Scholar 

  15. Boczkowski D, Nair SK, Snyder D, Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med. 1996;184:465–72.

    Article  CAS  PubMed  Google Scholar 

  16. Zhang W, He L, Yuan Z, Xie Z, Wang J, Hamada H, et al. Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin. Hum Gene Ther. 1999;10:1151–61.

    Article  CAS  PubMed  Google Scholar 

  17. Koido S, Kashiwaba M, Chen D, Gendler S, Kufe D, Gong J. Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA. J Immunol. 2000;165:5713–9.

    Article  CAS  PubMed  Google Scholar 

  18. Nair SK, Boczkowski D, Morse M, Cumming RI, Lyerly HK, Gilboa E. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nat Biotechnol. 1998;16:364–9.

    Article  CAS  PubMed  Google Scholar 

  19. Nair SK, Hull S, Coleman D, Gilboa E, Lyerly HK, Morse MA. Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA. Int J Cancer. 1999;82:121–4.

    Article  CAS  PubMed  Google Scholar 

  20. Nair SK, Morse M, Boczkowski D, Cumming RI, Vasovic L, Gilboa E, et al. Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells. Ann Surg. 2002;235:540–9.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Nair SK, Heiser A, Boczkowski D, Majumdar A, Naoe M, Lebkowski JS, et al. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nat Med. 2000;6:1011–7.

    Article  CAS  PubMed  Google Scholar 

  22. Boczkowski D, Nair SK, Nam JH, Lyerly HK, Gilboa E. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells. Cancer Res. 2000;60:1028–34.

    CAS  PubMed  Google Scholar 

  23. Heiser A, Maurice MA, Yancey DR, Coleman DM, Dahm P, Vieweg J. Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors. Cancer Res. 2001;61:3388–93.

    CAS  PubMed  Google Scholar 

  24. Heiser A, Maurice MA, Yancey DR, Wu NZ, Dahm P, Pruitt SK, et al. Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA. J Immunol. 2001;166:2953–60.

    Article  CAS  PubMed  Google Scholar 

  25. Heiser A, Dahm P, Yancey DR, Maurice MA, Boczkowski D, Nair SK, et al. Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro. J Immunol. 2000;164:5508–14.

    Article  CAS  PubMed  Google Scholar 

  26. Su Z, Dannull J, Heiser A, Yancey D, Pruitt S, Madden J, et al. Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells. Cancer Res. 2003;63:2127–33.

    CAS  PubMed  Google Scholar 

  27. Yewdall AW, Drutman SB, Jinwala F, Bahjat KS, Bhardwaj N. CD8+ T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cells. PLoS One. 2010. doi:10.1371/journal.pone.0011144.

    PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

The study was supported by grants from the National Natural Science Foundation of China (No. 30600156); the Science and Technology Projects Foundation of Guangdong Province (No. 2011B031800022); and the Youth Foundation of Jiangxi Province Education Department (No. Gjj10232).

Conflict of interest

None declared.

Author information

Authors and Affiliations

  1. Department of Hepatobiliary Surgery, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, People’s Republic of China

    B. H. Xie, B. G. Peng, L. J. Liang & Q. He

  2. Department of General Surgery, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, People’s Republic of China

    B. H. Xie

  3. Department of Interventional Radiology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, People’s Republic of China

    J. Y. Yang, H. P. Li, B. Zhang, W. Chen & B. Zhou

Authors
  1. B. H. Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Y. Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. P. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B. Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. G. Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. L. J. Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Q. He
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. P. Li.

Additional information

B. H. Xie and J. Y. Yang contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xie, B.H., Yang, J.Y., Li, H.P. et al. Dendritic cells transfected with hepatocellular carcinoma (HCC) total RNA induce specific immune responses against HCC in vitro and in vivo. Clin Transl Oncol 16, 753–760 (2014). https://doi.org/10.1007/s12094-013-1145-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-013-1145-7

Keywords

Search

Navigation